Cytosorbents Corp. (NASDAQ: CTSO) Starts Presentation at LD Micro Main Event
CytoSorbents (NASDAQ: CTSO) delivers critical care immunotherapy, specializing in blood purification. Its flagship product, CytoSorb®, is approved in the European Union with distribution in 44 countries around the world, as a safe and effective extracorporeal cytokine absorber, designed to reduce the “cytokine storm” or “cytokine release syndrome” that could otherwise cause massive inflammation, organ failure and death in common critical illnesses such as sepsis, burn injury, trauma, lung injury and pancreatitis, as well as in cancer immunotherapy. The company has numerous products under development based upon its unique blood purification technology. For more information, visit the company’s website at www.cytosorbents.com.…